| Edit |   |
|---|
| Product Name | Recombinant Human OX40 Ligand/TNFSF4 Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 28-34 kDa, reducing conditions. MW (theoretical): 18 kDa. The Recombinant Human OX40 Ligand/TNFSF4 Protein from R&D Systems is derived from NS0. The Recombinant Human OX40 Ligand/TNFSF4 Protein has been validated for the following applications: Bioactivity, Binding Activity. |
|---|
| Size | 10 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity, Binding Activity |
|---|
| Other Names | CD134 ligand, CD134L, CD252, CD252 antigen, Glycoprotein Gp34, gp34, OX40 antigen ligand, OX40 ligand, OX40L, OX-40L, OX4OL, TAX transcriptionally-activated glycoprotein 1, tax-transcriptionally activated glycoprotein 1 (34kD), tax-transcriptionally activated glycoprotein 1, 34kD, TNFSF4, tumor necrosis factor (ligand) superfamily, member 4, tumor necrosis factor ligand superfamily member 4, TXGP1 |
|---|
| Gene, Accession, CAS # | TNFSF4, Gene ID: 7292, Accession: Q6FGS4 |
|---|
| Catalog # | 1054-OX-010 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human OX40 Ligand/TNFSF4 Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 16840353, 18703465, 21454693, 29944697 |
|---|